secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2025-07-30T23:59:59+00:00
Accession:  0001641172-25-021552
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics granted Japan patent for modified stilbenoid epilepsy drug candidates
--------------------------------------------------------------------------------

- Japanese Patent Office granted Patent JP 7714571B on July 18, 2025, covering modified stilbenoid compounds.
- Patent runs until March 31, 2041, providing exclusivity for treating epilepsy and seizures.
- Builds on previously granted UK patent GB2609814 for same program.
- Japanese pharma market worth >$85B; global epilepsy drug market expected to reach $18.7B by 2034.
- Company expects to expand patent protection to other territories.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000164117225021552/0001641172-25-021552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000164117225021552/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-021552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer